● --:--
Last updated 2026-05-12
NOW
ServiceNow, Inc.
AI Software · Enterprise Workflow & Agentic Orchestration
📌 Current holding · ~5.53% NLV
$91.18
Mkt Cap ~$93.9B
52W: $81.24 – $211.48
Next earnings: late Jul 2026 (Q2 FY26)
⏸ Hold · Staged Add <$90
Entry zone: $80–$95
⚠ Fwd P/E variance: StockAnalysis 21.0× · GuruFocus 22.0× · FinanceCharts 24.6× (~17% band, driven by NTM EPS estimate spread $3.57–$4.55). Consensus midpoint ~22×.
The Street is selling NOW as a deceleration-and-DOGE story; the company just told the Street its AI ACV target jumped 50% mid-year ($1.0B → $1.5B), its 2030 subscription target is $30B+ at Rule-of-60, and at ~22× forward P/E it now trades at roughly the software industry median while still growing organic subscription revenue ~19% CC — the highest-conviction multiple-compression rerating opportunity in the AI applications layer.
Fwd P/E (NTM)
~22×2,8
PEG 0.83 (g=26% NTM) · vs 3Y avg ~50×
Rev YoY (latest Q)
+19%1
CC · QoQ →
Gross Margin
81.5%1
Sub · TTM ↑
FCF Margin (TTM)
44%1
Q1 adj ⚠ · FY26g 35%
EPS Revision (90d)
⚠ data pending
Next Earnings
Late Jul
Q2 FY26 · Est
NRR
⚠ not separately disclosed1
Rule of 40
~51
g 19% + adj op margin ~32%1
Thesis Durability
A
Variant perception is crisp: market is pricing a deceleration scare; management just raised the AI monetization bar 50% mid-year and laid down a $30B+ 2030 target7. $27.7B RPO (≈2× annual revenue) and 97% renewal rate make durability measurable, not narrative. AI = 30%+ of ACV by 2030 with AI inference <10% of cost-to-serve protects gross margin defensibility3. Bear stress-test: organic cRPO CC step-down from 21% (Q1) → ~18% (Q2 guide ex-Armis) is the real friction, but at 22× forward this is priced.
Thesis got stronger post-Analyst Day. Every datapoint a bull would have asked for printed; the multiple, not the fundamentals, broke.
Business Quality
A
81.5% subscription gross margin (FY26 guide)1, 32.0% non-GAAP op margin Q1 (FY guide 31.5%), 44% Q1 FCF margin. Rule-of-60+ targeted by 2030. $500M internal AI value generation in 2025 (~$300M cumulative OpEx savings into 2026) with flat headcount3. 16 deals >$5M NNACV in Q1 (+~80% YoY); 630 customers >$5M ACV.
Flow notes:
  • CEO Bill McDermott bought 28,682 shares open-market on 2026-02-27 at ~$105 (~$3.0M, non-10b5-1)10 — meaningful conviction signal, currently underwater.
  • No insider sell clusters; CFO/President activity is routine RSU vests and small 10b5-1 sales.
  • Short interest 3.78% of float2 — non-extended.
  • No tracked Dataroma superinvestor >25% position change in latest filings (45-day lag).
Highest-quality SaaS franchise outside the hyperscalers. Margin reset is M&A-driven (Armis 200 bps FCF), not organic deterioration.
Entry Price Discipline
A-
Forward P/E ~22×2,8 vs NOW's own 3-year average ~110× (FinanceCharts11) — an ~80% compression. Roughly in line with software industry median (~18.7×) despite NOW growing ~2× faster. PEG 0.83 (StockAnalysis2). Sell-side median PT $1402,4 = +53% upside; Bernstein top-end $236, KeyBanc bottom $85. CEO underwater on his $105 February buy — pure asymmetric dislocation.
Position vs entry zone: At $91, inside the revised $80–$95 zone but not at the floor. Single tranche adds discouraged; staged adds at $<90 and $<82 preferred.
Inside entry zone, not at floor. Stage in tranches rather than concentrate; CEO's own basis ($105) underwater protects against catching a falling knife thesis.
Verdict
The thesis that placed NOW in the book as a "Strong Add" rerating opportunity has, on the fundamental side, been confirmed and extended at Analyst Day (4 May) and Knowledge 2026 (5–7 May). The bear case did not break the thesis — it broke the multiple. At ~22× forward earnings for a business growing organic subscription revenue 19% CC with 81.5% gross margin and a Rule-of-60 2030 target, this is what mispriced compounding looks like. The frictions are real but priced: cRPO organic deceleration to ~18% CC, DOGE federal headwind, and a 200 bps FCF margin cut from the $7.75B Armis acquisition. None invalidate the variant perception; all are reflected in the multiple.
Hold at current ~5.53% NLV. Pre-authorize staged adds: +~1.0 pp NLV at <$90 USD if Q2 cRPO organic ≥18% CC; +~1.0 pp NLV unconditional at <$82 USD. Target post-Q2 weight: 7.5–8.0% NLV. Hard cap on this position: 9% NLV without a clear AI ACV beat or sub-$80 retest. 20% single-stock cap not the binding constraint here — valuation is.
Opportunity-cost check
vs CSPX (40% NLV)
22× forward P/E + 19% organic CC growth → forward earnings yield ~4.5% + double-digit growth runway versus CSPX's ~6–8% NTM expected. Multiple compression that's already happened on NOW is a stronger setup than rotating more into S&P 500 at near-record P/E. NOW wins.
vs current holdings
vs PLTR (5.4%, ~110× fwd): NOW is 5× cheaper on growth-adjusted basis. vs GOOGL/META (5%, 22–25× fwd, ~30% growth): comparable multiples but NOW has more visible AI ACV. vs MU (8%, memory cyclical): different exposure, complementary. Adds to NOW preferred over funding PLTR; do not fund by trimming MU/GOOGL/META.
vs dry powder
~19.5% NLV in cash is high. Two staged NOW adds deploy ~2 pp NLV; ample dry powder remains for other Stage 1/2 names (TSM, AVGO, GOOGL). NOW is not the only candidate — sequence relative to TSM / CRM entries.
Thesis-breakers

Three falsifiers. Any one trips → trim to 3%. Any two → exit.

  • 01Organic cRPO CC growth (strip 125 bps Armis contribution) <16% in two consecutive quarters · By Q3 FY26 print (Oct 2026)
  • 02Now Assist FY26 ACV walked back from $1.5B target, or Q3 disclosure implies <$1.2B run-rate · By Q3 FY26 print (Oct 2026)
  • 03Non-GAAP op margin <30% ex-Armis (i.e., real margin compression beyond M&A drag) in two consecutive quarters · By Q4 FY26 print (Jan 2027)
Key risks
  • 01DOGE / federal contract risk: HUD audit publicly cited 35,855 NOW licenses across 3 products with only 84 in active use12. Federal segment is mid-single-digit % of revenue but disproportionate on cRPO; estimated ~$200–400M of FY27 subscription revenue at risk in adverse case.
  • 02cRPO organic deceleration: Q1 21% CC → Q2 guide ~18% CC organic (ex-Armis). Each further 100 bps step-down is ~$150M of FY27 subscription revenue. KeyBanc is calling for single-digit organic bookings.
  • 03Armis dilution & integration: $7.75B cash deal closed 2026-04-20. Cuts FY26 FCF margin 200 bps (~$300M of foregone FCF on $15.77B revenue) and op margin 75 bps. Execution risk on integration at scale.
  • 04AI seat cannibalization: Bear case is that Now Assist agents displace seat licenses faster than they add consumption ACV. Management's 6.5× value-capture math on freed seats is unproven at scale beyond pilot deployments.
  • 05Salesforce Agentforce + MSFT Copilot competition: Both compete directly for the "AI control tower" mindshare. Microsoft Agent 365 integration was framed as partnership at Knowledge 2026 but is a structurally frenemy relationship.
DCF scenarios

Discount rate: 11% — high-growth profitable tech profile per project guide. Inputs: FY26 FCF guide ~$5.52B (35% × $15.77B); 1.03B shares; terminal growth 5%.

5Y sub rev CAGR
22%
Terminal FCF margin
38%
Fair value / share
~$170–185
vs current
+86–103%

Bull: 22% sub growth sustained 5 yrs, Rule-of-60 achieved by 2030, terminal FCF margin expands 35% → 38% as AI ACV mix hits 30%. 2030 revenue ~$31B, 2030 FCF ~$11.8B. Roughly consistent with Bernstein's $236 PT at higher margin assumption.

5Y sub rev CAGR
17.5%
Terminal FCF margin
36%
Fair value / share
~$135–145
vs current
+48–59%

Base: 17.5% CAGR hits the $30B 2030 target exactly; FCF margin holds 35–36%. Matches Street consensus median PT ~$140.

5Y sub rev CAGR
13%
Terminal FCF margin
32%
Fair value / share
~$85–95
vs current
−7 to +4%

Bear: immediate 30% deceleration to 13% growth, AI cost pressure compresses FCF margin to 32% by 2030, 2030 revenue ~$23B. Matches KeyBanc's $85 PT.

Position: Current $91.18 is at the bear-case floor. Market is pricing the bear case as base case — that's the asymmetric setup.
Catalyst timeline
  • 2026-07 (late)
    Q2 FY26 print. Critical watchpoints: organic cRPO ex-Armis (need ≥18% CC); Now Assist ACV update vs $1.5B FY26 target; first quarter of full Armis contribution to subscription. Misses on cRPO would trigger thesis-breaker #1 watch.
  • 2026-09 to 10
    World Forum city events series. Pipeline signal — historically used to disclose new customer wins and AI Agent deployment counts.
  • 2026-10 (late)
    Q3 FY26 print. First read on AI agent consumption ramp; tests whether Now Assist trajectory is on track for $1.5B FY26 target.
  • 2027-01 (late)
    Q4 FY26 print + FY27 guide. Annual reset; first FY27 cRPO guide. This is the print that confirms or breaks the $30B-by-2030 trajectory.
  • 2027-05-04 to 06
    Knowledge 2027 (20th anniversary) + likely Analyst Day refresh. Long-dated catalyst but historically a multiple-rerating event.
Named analyst commentary
No coverage from tracked analysts (Beth Kindig, Serenity @aleabitoreddit, Dylan Patel / SemiAnalysis). All three frameworks are AI infrastructure / bottleneck-focused (compute, memory, networking, power); enterprise workflow SaaS is structurally outside their lane. Absence is a coverage-universe mismatch, not a quality knock.
SELL-SIDE (for context, not framework-aligned)
"[ServiceNow] did all it could do to increase confidence in the investment story" — driven by AI innovation and TAM expansion across a "$600B addressable market."
— Barclays (Overweight, $134, raised from $132), 2026-05-0513
Analyst Day was a "long-term margin and free cash flow win" with implied 900 bps FCF margin expansion vs 2025; concedes "they also fed the bears" with the $30B target implying mid-teens deceleration.
— Bernstein (Peter Weed, Outperform, $236, raised from $226), 2026-05-0614
"Growing faster than any other enterprise software company at scale in the world. Ever." (re: $27.7B RPO ≈ 2× annual revenue)
— Bill McDermott (CEO, ServiceNow), CNBC interview, 2026-05-0515
Framework fit · why bottleneck-focused frameworks skip NOW

Bottleneck-focused frameworks (binding-constraint thinking — own the scarcest input in the AI stack: compute, memory, optical, power) typically skip enterprise SaaS. NOW occupies the enterprise workflow / agentic orchestration layer — one or two layers above the bottleneck. ServiceNow is a consumer of bottlenecks (it buys NVDA compute, runs on hyperscalers, integrates with optical fabric), not a bottleneck itself.

For this book: The mandate is broader than pure bottleneck-hunting — it explicitly accommodates "AI-beneficiary at GARP price." NOW at ~22× forward with 19% organic growth and Rule-of-60-by-2030 is precisely the dislocation a flexible mandate should exploit. Including NOW is a deliberate framework choice (own a layer up at the right price), not a framework error.

Distinction from Inflexion Capital list (separate framework): Inflexion did not include NOW in their 5-star list. Our framework upgrades NOW relative to Inflexion on the basis of the post-May-2025 multiple compression to ~22× — at that price, the GARP case is materially stronger than when Inflexion's list was last published.

Sources
1 SEC EDGAR — ServiceNow 8-K (Q1 FY26 earnings release), filed 2026-04-22
2 StockAnalysis.com — accessed 2026-05-12
3 ServiceNow Q1 FY26 earnings call transcript (Motley Fool / Yahoo Finance, 2026-04-22)
4 WallStreetZen / Ticker Nerd — median PT $139.35–$140 (26–54 analyst sample); StockAnalysis mean $184 distorted by $1,160 outlier
5 Robinhood / FullRatio — 52-week range and intraday quote
6 ServiceNow Newsroom — Q1 FY26 press release, 2026-04-22
7 Yahoo Finance / Fortune — Analyst Day coverage, 2026-05-04 to 05-06
8 GuruFocus — forward P/E 22.04 (accessed 2026-05-12)
9 Public.com / FullRatio — TTM P/E 53.6–54.7 (accessed 2026-05-12)
10 Stocktitan — Form 4 filings (CEO 2026-02-27 open-market buy; CFO & President routine vests/sales)
11 FinanceCharts — historical P/E (3Y/5Y averages, accessed 2026-05-12)
12 X.com / DOGE official account — HUD software audit disclosure (35,855 licenses, 84 in use)
13 24/7 Wall St / Yahoo Finance — Barclays PT raise, 2026-05-05
14 Insider Monkey / 24/7 Wall St — Bernstein PT raise, 2026-05-06
15 CNBC interview — Bill McDermott, 2026-05-05 media quote, single source

= figure not verifiable from open-access sources or sourced from a single provider.

Forward P/E range across sources is 21.03–24.57 (within 17% band). NOW completed a 5:1 stock split on 2025-12-18; all historical price comparisons in this analysis are split-adjusted.